ME
VIVS

McIlrath & Eck’s VivoSim Labs VIVS Stock Holding History

McIlrath & Eck’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2
Closed -$3 – 989
2025
Q2 		$3 Hold
2
– – ﹤0.01% 930
2025
Q1 		$4 Sell
2
-1
-33% -$5 ﹤0.01% 926
2024
Q4 		$16 Hold
3
– – ﹤0.01% 972
2024
Q3 		$18 Hold
3
– – ﹤0.01% 974
2024
Q2 		$27 Buy
+3
New +$35 ﹤0.01% 945
2024
Q1 		– Sell
-3
Closed -$39 – 968
2023
Q4 		$39 Buy
+3
New +$45 ﹤0.01% 917

Other funds holding VIVS

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

McIlrath & Eck's VIVS Position: Q3 2025 in Review

McIlrath & Eck sold out of VivoSim Labs (VIVS) in Q3 2025, closing a stake of 2 shares — an estimated $3 sold.

McIlrath & Eck first reported a position in VIVS in Q4 2023 and held it in 6 quarters. The position peaked at $39 in Q4 2023. 29 funds tracked by Wall St. Rank hold VIVS as of Q3 2025.

  • McIlrath & Eck reported no remaining VivoSim Labs position as of Q3 2025 after selling out during the quarter.
  • McIlrath & Eck sold 2 VivoSim Labs shares in Q3 2025, an estimated $3.
  • McIlrath & Eck first reported a position in VivoSim Labs in Q4 2023 and held it in 6 quarters.
  • McIlrath & Eck's VivoSim Labs position peaked at $39 in Q4 2023.
  • 29 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2025.

Based on McIlrath & Eck's 13F filing for Q3 2025, filed 22 Oct 2025.